📰 Dana Walker News
Page 2 - Dana Walker News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dana Walker. Real-time updates on events, politics, business and more.
April 26, 2024
Frontline nivolumab plus chemotherapy has been recommended for approval in unresectable or metastatic urothelial carcinoma.
April 26, 2024
Bristol Myers Squibb announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of Opdivo in combination with cisplatin...
April 11, 2024
Hall County Schools Superintendent Will Schofield announced Wednesday three district staff changes.
March 12, 2024
Bulli FC seniors show goodwill by pledging $20,000 to support Bulli Junior Football Club, aiding in funding new facilities and lighting for young players.
January 24, 2024
Compared with chemotherapy, nivolumab plus ipilimumab reduced the risk of disease progression or death by 79%, but further research is needed to assess overall survival.
January 23, 2024
PRINCETON - Bristol Myers Squibb today announced that Opdivo plus Yervoy continued to demonstrate long-term survival results in the Phase 3 CheckMate -214 trial, reducing the risk of death by 28%...
January 22, 2024
Opdivo in combination with CABOMETYX reduced the risk of death by 23% in the first-line treatment of advanced renal cell carcinoma vs. sunitinib Four-year results demonstrating continued benefits...
January 22, 2024
Patients with previously untreated advanced or metastatic renal cell carcinoma treated with Opdivo plus Yervoy experienced a 28% reduction in the risk of death vs. sunitinib at eight years from the...
January 20, 2024
First presentation of data from the Phase 3 randomized trial shows statistically significant and clinically meaningful improvement in progression-free survival with Opdivo plus Yervoy compared to...